title: Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype.
abstract: BACKGROUND
  Malignant pleural mesothelioma is considered an almost incurable tumour with increasing incidence worldwide. It usually develops in the parietal pleura, from mesothelial lining or submesothelial cells, subsequently invading the visceral pleura. Chromosomal and genomic aberrations of mesothelioma are diverse and heterogenous. Genome-wide profiling of mesothelioma versus parietal and visceral normal pleural tissue could thus reveal novel genes and pathways explaining its aggressive phenotype.
  
  
  RESULTS
  Well-characterised tissue from five mesothelioma patients and normal parietal and visceral pleural samples from six non-cancer patients were profiled by Affymetrix oligoarray of 38 500 genes. The lists of differentially expressed genes tested for overrepresentation in KEGG PATHWAYS (Kyoto Encyclopedia of Genes and Genomes) and GO (gene ontology) terms revealed large differences of expression between visceral and parietal pleura, and both tissues differed from mesothelioma. Cell growth and intrinsic resistance in tumour versus parietal pleura was reflected in highly overexpressed cell cycle, mitosis, replication, DNA repair and anti-apoptosis genes. Several genes of the "salvage pathway" that recycle nucleobases were overexpressed, among them TYMS, encoding thymidylate synthase, the main target of the antifolate drug pemetrexed that is active in mesothelioma. Circadian rhythm genes were expressed in favour of tumour growth. The local invasive, non-metastatic phenotype of mesothelioma, could partly be due to overexpression of the known metastasis suppressors NME1 and NME2. Down-regulation of several tumour suppressor genes could contribute to mesothelioma progression. Genes involved in cell communication were down-regulated, indicating that mesothelioma may shield itself from the immune system. Similarly, in non-cancer parietal versus visceral pleura signal transduction, soluble transporter and adhesion genes were down-regulated. This could represent a genetical platform of the parietal pleura propensity to develop mesothelioma.
  
  
  CONCLUSIONS
  Genome-wide microarray approach using complex human tissue samples revealed novel expression patterns, reflecting some important features of mesothelioma biology that should be further explored.
authors: Department of Oncology, St Olavs Hospital, University Hospital of Trondheim, Trondheim, Norway. olufdroe@yahoo.no
authors: Oluf Dimitri
authors: OD
authors: Røe
authors: Endre
authors: E
authors: Anderssen
authors: Eli
authors: E
authors: Helge
authors: Caroline Hild
authors: CH
authors: Pettersen
authors: Karina Standahl
authors: KS
authors: Olsen
authors: Helmut
authors: H
authors: Sandeck
authors: Rune
authors: R
authors: Haaverstad
authors: Steinar
authors: S
authors: Lundgren
authors: Erik
authors: E
authors: Larsson
mesh_terms: D000293:Adolescent; D000328:Adult; D017209:Apoptosis / Q000235:genetics; D002453:Cell Cycle / Q000235:genetics; D002940:Circadian Rhythm; D004260:DNA Repair / Q000235:genetics; D005260:Female; D020869:Gene Expression Profiling; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000098:blood supply / Q000235:genetics* / Q000473:pathology; D008875:Middle Aged; D008938:Mitosis / Q000235:genetics; D009362:Neoplasm Metastasis; D009389:Neovascularization, Pathologic; D010641:Phenotype; D010997:Pleural Neoplasms / Q000098:blood supply / Q000235:genetics* / Q000473:pathology